Animal Health
Swine Autogenous Vaccines Market

Swine Autogenous Vaccines Market Size, Share, Trends, and Growth Forecasts 2025 - 2032

Swine Autogenous Vaccine Market by Strain Type (Bacterial Strain, Viral Strain), by Application (Respiratory Diseases, Gastrointestinal Diseases, Reproductive Diseases, Systemic Infections, Others), by End-user, and Region for 2025 - 2032

ID: PMRREP35209

April 2025

150 Pages

Author : Pravin Rewale

Healthcare

Swine Autogenous Vaccines Market Share and Trends Analysis

The global swine autogenous vaccines market is estimated to grow from US$ 48.7 million in 2025 to US$ 70.0 million to record a CAGR of 5.3% by 2032. According to Persistence Market Research, report, the rising prevalence of farm-specific and region-specific swine diseases that commercial vaccines fail to address effectively fuels the need. Autogenous vaccines developed using pathogens isolated directly from affected herds, offer a targeted disease control solution while supporting antibiotic reduction efforts in livestock farming.

The widespread adoption of vertically integrated swine production systems in North America streamlines disease surveillance and accelerates deployment of autogenous vaccines. Meanwhile, East Asia is emerging as a high-potential market where modernization efforts and improved biosecurity are encouraging the uptake of herd-specific vaccination strategies. These systems streamline disease surveillance, enable rapid diagnostics, and facilitate timely vaccine deployment, strengthening herd health and biosecurity. Additionally, regulatory support for customized vaccines, especially in the U.S. and Europe encourages a broader adoption.

Technological advancements are also reshaping the industry. Platforms like SEQUIVITY® by Merck Animal Health use RNA particle technology to develop herd-specific prescription vaccines for pathogens such as Influenza A Virus in Swine (IAV-S), Porcine Circovirus (PCV), and rotavirus. This innovation enables rapid, multivalent vaccine production without handling live pathogens, improving both safety and efficiency. Furthermore, collaborations between major industry players, including Boehringer Ingelheim and Ceva Animal Health, continue to improve vaccine accessibility, particularly in emerging markets. As demand for farm-specific disease management solutions grows, advancements in diagnostics and biosecurity measures are expected to drive further expansion of the swine autogenous vaccine market globally.

Key Industry Highlights:

The industry is growing as swine producers face increasing challenges from evolving pathogens and new disease outbreaks not covered by commercial vaccines.
Streamlined regulatory pathways in regions such as the U.S. and EU have encouraged wider adoption of autogenous vaccines.
Growing swine industries in Asia Pacific and Latin America present untapped potential for autogenous vaccines, especially where commercial vaccines are less effective or unavailable.
Innovations in pathogen sequencing and rapid diagnostics enable quicker identification of herd-specific pathogens, supporting more precise and faster vaccine development.
The rise of vertically integrated farming systems with high biosecurity standards makes custom vaccines more viable and valuable.

Global Market Attribute	Key Insights
Swine Autogenous Vaccines Market Size (2025E)	US$ 48.7 Mn
Market Value Forecast (2032F)	US$ 70.0 Mn
Projected Growth (CAGR 2025 to 2032)	5.3%
Historical Market Growth (CAGR 2019 to 2024)	4.1%

Market Dynamic

Driver - Precision Livestock Farming Driving Autogenous Vaccine Adoption

The adoption of precision livestock farming (PLF) is transforming swine health management by enabling early disease detection, data-driven decision-making, and targeted autogenous vaccine use. AI-driven sensors, automated monitoring, and predictive analytics help identify pathogens early, reducing disease outbreaks and improving herd productivity. In February 2023, MACSO Technologies Limited deployed AI-powered sensors on a U.S. swine farm, cutting mortality rates to 1.4% in monitored barns compared to 5.7% in others, demonstrating the impact of real-time health monitoring.

Initiative such as the USDA’s Precision Geospatial & Sensor Technologies program are further advancing disease prevention by integrating precision diagnostics and biosecurity measures. These advancements enhance vaccine effectiveness, allowing swine producers to implement customized immunization strategies tailored to farm-specific disease risks. As PLF adoption grows, autogenous vaccines are becoming increasingly vital in modern swine health management, offering a proactive approach to disease control and herd protection.

Restraint - Limited Awareness Among Small-Scale Producers

A significant restraint in the swine autogenous vaccine market is the limited awareness and understanding among small and independent producers regarding the benefits and availability of customized vaccines. These farmers often rely on conventional commercial vaccines or traditional disease management practices due to limited exposure to newer, farm-specific solutions. For example, in several parts of Southeast Asia and Latin America, smallholder farms represent a large portion of pork production but typically lack access to veterinary consultations or the diagnostic support necessary for autogenous vaccine use. This knowledge gap hinders adoption despite the growing need for targeted disease control measures in densely stocked and resource-limited environments. Bridging this awareness gap through training programs, government initiatives, and veterinary outreach could be vital for expanding market reach.

Opportunity - Innovative Vaccine Platforms Enhancing Efficiency and Scalability

Advancements in vaccine development technologies are driving new opportunities in the swine autogenous vaccine market, making these solutions more efficient, scalable, and accessible. Innovations such as RNA particle vaccines-exemplified by Merck’s SEQUIVITY® platform-allow for rapid, herd-specific vaccine development without handling live pathogens, significantly reducing production time. Additionally, protein subunit platforms like those developed by Medgene Labs, enhance vaccine stability and immune response ensuring safer and targeted disease prevention. These advancements enable faster adaptation to emerging swine diseases, improving herd health and biosecurity while expanding the global adoption of autogenous vaccine strategies.

Get Your CustomizationGet Your Customization

Market Insights and Trends

Strain Type Insights

The bacterial strain segment is projected to dominate accounting for a 54.2% share in 2025. Live bacterial vaccines mimic infections, enhance immune response, and allows oral administration, making them ideal for herd-specific disease control. Rising cases of Actinobacillus Pleuropneumonia and Streptococcus suis along with reduced antibiotic use drives demand for custom bacterial vaccines.

The viral strain segment is gaining traction with increasing demand for autogenous vaccines targeting Porcine Reproductive and Respiratory Syndrome (PRRS) and Influenza A, where commercial vaccines show limited efficacy.

End-user Insights

In 2025, livestock farming companies are expected to dominate the swine autogenous vaccine market, accounting for approximately 63.2% of the total market share. This dominance is driven by the increasing need for farm-specific disease management, particularly in large-scale swine production systems. With the rising concerns over emerging disease threats and restrictions on antibiotic use, swine producers are turning to autogenous vaccines for tailored protection against localized pathogens. Moreover, the adoption of data-driven disease management strategies is further boosting the use of autogenous vaccines, allowing for more effective herd protection, and reduced economic losses.

While veterinary clinics and hospitals play a crucial role in diagnostics and vaccine administration, and veterinary research institutes contribute to vaccine development, livestock farming companies remain the primary end-users, as they directly benefit from customized vaccines to improve herd health and productivity.

swine autogenous vaccines market insights and key trends

Regional Insights and Trends

North America Swine Autogenous Vaccines Market Trends

In 2025, North America is expected to hold 34.2% of the global swine autogenous vaccine market, with the U.S. leading the segment due to strong USDA regulatory oversight and an advanced veterinary infrastructure. The U.S. swine autogenous vaccine market is poised for steady growth, driven by rising disease threats, antibiotic restrictions, and advancements in precision livestock farming. In the early 2025, American Association of Swine Veterinarians (AASV) Industry Support Council aligned a collective discussion upon emerging disease threats, vaccine advancements, and biosecurity improvements with leading companies such as Merck Animal Health, Zoetis, and Ceva Animal Health.

Europe Swine Autogenous Vaccines Market Trends

By 2025, Europe is expected to account for 24.1% of the global swine autogenous vaccine market, driven by strong regulations and industry-led initiatives. In November 2024, the World Organization for Animal Health (WOAH) initiated a research publication on autogenous vaccines, following recommendations from the Second Global Conference on Antimicrobial Resistance, aiming to establish standardized guidelines as alternatives to antimicrobials. This regulatory advancement positions Europe as a key player in enhancing disease control strategies for swine herds, reinforcing its role in the global autogenous vaccine market.

Asia Pacific Swine Autogenous Vaccines Market

East Asia swine autogenous vaccine market is set to capture a 17.2% global share in 2025 driven by the region’s expanding pork industry and growing demand for customized disease management. According to recent data published in 2022, China produced approximately 52 million tonnes of pork, representing 44.1% of global pork production, with the industry valued at around $150 billion. Frequent disease outbreaks, including African Swine Fever, have intensified the need for enhanced biosecurity and herd-specific vaccines. As both large-scale farms and small-scale operations adopt advanced health strategies, the demand for autogenous vaccines continue to grow across the region.

Request Free sampleRequest Free sample

Competitive Landscape

The global swine autogenous vaccine market is highly fragmented, with numerous manufacturers developing customized solutions for herd-specific disease management. The market encompasses a variety of vaccine formulations, including bacterial and viral strains, tailored to address emerging health threats in different regions. Advancements in diagnostics and vaccine production technologies are improving efficacy, accessibility, and adoption, driving market growth.

Key Industry Developments

In November 2023, DKSH’s Business Unit Performance Materials partnered with Pharmgate to distribute its swine vaccines across Cambodia, Laos, Myanmar, and Thailand. DKSH provides business development, sales, logistics, product registration, and technical support, expanding Pharmgate’s presence in South-East Asia and strengthening access to specialized swine health solutions in the region.
In May 2023, Elanco Animal Health entered an exclusive agreement with Aptimmune Biologics to distribute its inactivated PRRS vaccine in the U.S. The vaccine, developed using Aptimmune’s Barricade® technology, aims to enhance protection against PRRS in swine. This partnership strengthens Elanco’s swine vaccine portfolio and expands access to innovative disease prevention solutions.

Companies Covered in Swine Autogenous Vaccines Market

Ceva
Phibro Animal Health Corporation
SAN Group Biotech Germany GmbH
Exopol
Vaxxinova
?American Animal Health, Inc.
BIMEDA® BIOLOGICALS
Dopharma
Elanco
Tréidlia Biovet
Cambridge Technologies
Addison Biological Laboratory
VST Labs
INVAC Deutschland GmbH
Merck & Co., Inc.
Wixbio
Boehringer Ingelheim Animal Health USA Inc.
Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH
Dyntec
Aptimmune

Frequently Asked Questions

The global swine autogenous vaccines market is estimated to increase from US$ 48.7 Mn in 2025 to US$ 70.0 Mn in 2032.

Rising farm-specific disease outbreaks, increasing restrictions on antibiotics, advancements in precision livestock farming, and the growing demand for customized disease management solutions.

The market is projected to record a CAGR of 5.3% during the forecast period from 2025 to 2032.

Opportunities in the swine autogenous vaccine market include increasing demand for personalized vaccine solutions to combat emerging infectious diseases and improve herd health management in the swine industry.

Key players in the swine autogenous vaccines market include Merck & Co., Inc., Ceva Animal Health, Phibro Animal Health, Vaxxinova, and Dopharma, among others.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Swine Autogenous Vaccines Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Disease Epidemiology
3. Technological Advancement
4. Regulatory Landscape
5. Value Chain Analysis
6. Key Deals and Mergers
7. PESTLE Analysis
8. Porter’s Five Force Analysis
Global Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
3. Global Swine Autogenous Vaccines Market Outlook: Strain Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, by Strain Type, 2019-2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
    1. Bacterial Strain
    2. Viral Strain
  4. Market Attractiveness Analysis: Strain Type
4. Global Swine Autogenous Vaccines Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, by Application, 2019-2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
    1. Respiratory Diseases
    2. Gastrointestinal Diseases
    3. Reproductive Diseases
    4. Systemic Infections
    5. Others
  4. Market Attractiveness Analysis: Application
5. Global Swine Autogenous Vaccines Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, by End User, 2019-2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
    1. Veterinary Clinics and Hospitals
    2. Livestock Farming Companies
    3. Research and Academic Institutes
  4. Market Attractiveness Analysis: End User
Global Swine Autogenous Vaccines Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2024
3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
  1. U.S.
  2. Canada
4. Current Market Size (US$ Mn) Analysis and Forecast by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
Europe Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast, by Country, 2025-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
East Asia Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast, by Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
4. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
South Asia & Oceania Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast, by Country, 2025-2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
Latin America Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast, by Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
Middle East & Africa Swine Autogenous Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, by Market, 2019-2024
  1. by Country
  2. by Strain Type
  3. by Application
  4. by End User
3. Current Market Size (US$ Mn) Analysis and Forecast, by Country, 2025-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Current Market Size (US$ Mn) Analysis and Forecast, by Strain Type, 2025-2032
  1. Bacterial Strain
  2. Viral Strain
5. Current Market Size (US$ Mn) Analysis and Forecast, by Application, 2025-2032
  1. Respiratory Diseases
  2. Gastrointestinal Diseases
  3. Reproductive Diseases
  4. Systemic Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, by End User, 2025-2032
  1. Veterinary Clinics and Hospitals
  2. Livestock Farming Companies
  3. Research and Academic Institutes
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Ceva
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Phibro Animal Health Corporation
  3. SAN Group Biotech Germany GmbH
  4. Exopol
  5. Vaxxinova
  6. ?American Animal Health, Inc.
  7. BIMEDA® BIOLOGICALS
  8. Dopharma
  9. Elanco
  10. Tréidlia Biovet
  11. Cambridge Technologies
  12. Addison Biological Laboratory
  13. VST Labs
  14. INVAC Deutschland GmbH
  15. Merck & Co., Inc.
  16. Wixbio
  17. Boehringer Ingelheim Animal Health USA Inc.
  18. Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH
  19. Dyntec
  20. Aptimmune
  21. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Strain Type Application End-user Region
Competitive Analysis	Ceva Phibro Animal Health Corporation SAN Group Biotech Germany GmbH Exopol Vaxxinova American Animal Health, Inc. BIMEDA® BIOLOGICALS Dopharma Elanco Tréidlia Biovet Cambridge Technologies Addison Biological Laboratory VST Labs INVAC Deutschland GmbH Merck & Co., Inc. Wixbio Boehringer Ingelheim Animal Health USA Inc. Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Dyntec Aptimmune
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Strain Type Application End-user Region
Competitive Analysis	Ceva Phibro Animal Health Corporation SAN Group Biotech Germany GmbH Exopol Vaxxinova American Animal Health, Inc. BIMEDA® BIOLOGICALS Dopharma Elanco Tréidlia Biovet Cambridge Technologies Addison Biological Laboratory VST Labs INVAC Deutschland GmbH Merck & Co., Inc. Wixbio Boehringer Ingelheim Animal Health USA Inc. Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Dyntec Aptimmune
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

Swine Autogenous Vaccines Market Size, Share, Trends, and Growth Forecasts 2025 - 2032

Swine Autogenous Vaccine Market by Strain Type (Bacterial Strain, Viral Strain), by Application (Respiratory Diseases, Gastrointestinal Diseases, Reproductive Diseases, Systemic Infections, Others), by End-user, and Region for 2025 - 2032